Clinical Trials Logo
  1. Home
  2. Other
  3. NCT02057861

Reversal of Neuromuscular Blockade in Diabetic Patients

Observation of Neuromuscular Block Clinical Trial

Official title:
The Comparison of Reversal of Neuromuscular Blockade in Diabetic and Non-Diabetic Patients

Clinical Trial Summary

In this study the investigators aimed to compare the time of antagonism and intensity of effect of sugammadex which is used for antagonism of rocuronium on diabetic and non-diabetic patients.

Clinical Trial Description

Aim: In this study the investigators aimed to compare the time of antagonism and intensity of effect of sugammadex which is used for antagonism of rocuronium on diabetic and non-diabetic patients.

Methods: Included patients were divided into 2 groups: diabetic (n=21) and non-diabetic (n=20). All patients were premedicated. After arrival in the operating room, all patients were monitorised with Datex Ohmeda S/5 Anesthesia Machine and electrocardiography (DII derivation), hemodynamic variables, respiratory rate, and inspiratory sevoflurane concentrations were recorded. Neuromuscular monitoring system was used. Anesthesia was induced with propofol 2 mg/kg and fentanyl 1 mcg/kg. After the loss of eyelid reflex the neuromuscular monitoring system automatically identified supramaximal stimulating currents and after that rocuronium 0,6 mg/kg was given. Train of four (TOF) stimulation with the supramaximal current were applied and by recording of second TOF value (TOF2) the patient was intubated. Anesthesia was maintained with 50% O2 + 50% air and sevoflurane of 1-2 % concentration. TOF stimulation was applied and recorded every 20 seconds. Intraoperatively by return T2 rocuronium 0,15 mg/kg was given. T2i time was recorded as intubation time and T2d time was recorded as clinical effect time. At the end of the operation sugammadex 2 mg/kg was given. When TOF rate reached 0,9 patients were extubated and the time was recorded. ;

Study Design

Observational Model: Case Control, Time Perspective: Prospective

Related Conditions & MeSH terms

  • Observation of Neuromuscular Block
Clinical Trial Details
NCT number NCT02057861
Study type Observational [Patient Registry]
Source Duzce University
Contact
Status Completed
Phase N/A
Start date January 2013
Completion date December 2013
View Details
See also
  Status Clinical Trial Phase
Completed NCT02100293 - Effects of Magnesium Sulfate on Onset and Duration of Low Dose Rocuronium N/A
Withdrawn NCT01592630 - Effectiveness of Transverse Abdominus Plane Catheter Blocks to Patient-controlled Analgesia in Laparoscopic Colon Resections Phase 3
Completed NCT02318810 - Influence of the Neuromuscular Blockade on Mask Ventilation N/A
Completed NCT03420937 - Deep Neuromuscular Block During General Anaesthesia in Robotic Surgery Phase 4
Completed NCT01885715 - Appropriate Dose of Neostigmine for Reversal of Rocuronium and Cisatracurium N/A
Completed NCT01318382 - Residual Curarization and Its Incidence at Tracheal Extubation (P08194) Phase 4
Completed NCT01349751 - Clinical Characteristics of Spinal Levobupivacaine: Hyperbaric Compared With Isobaric Solution N/A
Withdrawn NCT02591108 - Train of Four Motor Point Stimulation and Monitoring N/A
Completed NCT02825121 - Evaluation of Monitoring Neuromuscular Blockade the Flexor Hallucis Compared to the Adductor Pollicis N/A
Completed NCT02602964 - A Trial Comparing Deep Versus Moderate Neuromuscular Block - in Low Pressure Pneumoperitoneum Phase 4
Completed NCT02126852 - Comparison of AMG and EMG to Avoid Residual Paralysis After General Anesthesia N/A